Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jun 26;11(7):1438.
doi: 10.3390/nu11071438.

Metabolic Syndrome-Role of Dietary Fat Type and Quantity

Peter Clifton  1
Affiliations
Review

Metabolic Syndrome-Role of Dietary Fat Type and Quantity

Peter Clifton. Nutrients. .

Abstract

Background: Metabolic syndrome increases the risk of cardiovascular disease (CVD) over and above that related to type 2 diabetes. The optimal diet for the treatment of metabolic syndrome is not clear.

Materials and methods: A review of dietary interventions in volunteers with metabolic syndrome as well as studies examining the impact of dietary fat on the separate components of metabolic syndrome was undertaken using only recent meta-analyses, if available.

Results: Most of the data suggest that replacing carbohydrates with any fat, but particularly polyunsaturated fat, will lower triglyceride(TG), increase high density lipoprotein (HDL) cholesterol, and lower blood pressure, but have no effects on fasting glucose in normal volunteers or insulin sensitivity, as assessed by euglycemic hyperinsulinemic clamps. Fasting insulin may be lowered by fat. Monounsaturated fat (MUFA) is preferable to polyunsaturated fat (PUFA) for fasting insulin and glucose lowering. The addition of 3-4 g of N3 fats will lower TG and blood pressure (BP) and reduce the proportion of subjects with metabolic syndrome. Dairy fat (50% saturated fat) is also related to a lower incidence of metabolic syndrome in cohort studies.

Keywords: blood pressure; carbohydrate; fish oil; glucose; insulin resistance; lipids; meta-analyses; monounsaturated fat; polyunsaturated fat; saturated fat.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595–1607. doi: 10.2337/diab.37.12.1595. - DOI - PubMed
    1. Kassi E., Pervanidou P., Kaltsas G., Chrousos G. Metabolic syndrome: Definitions and controversies. BMC Med. 2011;9:48. doi: 10.1186/1741-7015-9-48. - DOI - PMC - PubMed
    1. Mensink R.P., Zock P.L., Kester A.D., Katan M.B. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: A meta-analysis of 60 controlled trials. Am. J. Clin. Nutr. 2003;77:1146–1155. doi: 10.1093/ajcn/77.5.1146. - DOI - PubMed
    1. Vitali C., Khetarpal S.A., Rader D.J. Cholesterol Metabolism and the Risk of CHD: New Insights from Human Genetics. Curr. Cardiol. Rep. 2017;19:132. doi: 10.1007/s11886-017-0940-0. - DOI - PubMed
    1. Ference B.A., Kastelein J.J.P., Ray K.K., Ginsberg H.N., Chapman M.J., Packard C.J., Laufs U., Oliver-Williams C., Wood A.M., Butterworth A.S., et al. Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants with Risk of Coronary Heart Disease. JAMA. 2019;321:364–373. doi: 10.1001/jama.2018.20045. - DOI - PMC - PubMed

MeSH terms